Jay Shepard - Net Worth and Insider Trading

Jay Shepard Net Worth

The estimated net worth of Jay Shepard is at least $2,917 dollars as of 2024-11-13. Jay Shepard is the President and CEO of Aravive Inc and owns about 72,754 shares of Aravive Inc (ARAV) stock worth over $2,917. Details can be seen in Jay Shepard's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jay Shepard has not made any transactions after 2019-10-07 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Jay Shepard

Jay Shepard Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jay Shepard owns 6 companies in total, including Esperion Therapeutics Inc (ESPR) , Inovio Pharmaceuticals Inc (INO) , and Aravive Inc (ARAV) among others .

Click here to see the complete history of Jay Shepard’s form 4 insider trades.

Insider Ownership Summary of Jay Shepard

Ticker	Comapny	Transaction Date	Type of Owner
ESPR	Esperion Therapeutics Inc	2018-05-24	director
INO	Inovio Pharmaceuticals Inc	2020-01-15	director
ARAV	Aravive Inc	2019-10-07	director & President and CEO
		2014-07-31	director
		2013-09-26	director
		2020-12-03	director

Jay Shepard Latest Holdings Summary

Jay Shepard currently owns a total of 1 stock. Jay Shepard owns 72,754 shares of Aravive Inc (ARAV) as of October 7, 2019, with a value of $2,917.

Latest Holdings of Jay Shepard

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
ARAV	Aravive Inc	2019-10-07	72,754	0.04	2,917

Holding Weightings of Jay Shepard

Jay Shepard Form 4 Trading Tracker

According to the SEC Form 4 filings, Jay Shepard has made a total of 0 transactions in Aravive Inc (ARAV) over the past 5 years. The most-recent trade in Aravive Inc is the sale of 4,004 shares on October 7, 2019, which brought Jay Shepard around $27,307.

Insider Trading History of Jay Shepard

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Jay Shepard Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Jay Shepard Ownership Network

Ownership Network List of Jay Shepard

No Data

Ownership Network Relation of Jay Shepard

Jay Shepard Owned Company Details

What does Esperion Therapeutics Inc do?

Who are the key executives at Esperion Therapeutics Inc?

Jay Shepard is the director of Esperion Therapeutics Inc. Other key executives at Esperion Therapeutics Inc include Chief Commercial Officer Eric Warren , Chief Operating Officer Sheldon L. Koenig , and Chief Medical Officer Joanne M. Foody .

Esperion Therapeutics Inc (ESPR) Insider Trades Summary

Over the past 18 months, Jay Shepard made no insider transaction in Esperion Therapeutics Inc (ESPR). Other recent insider transactions involving Esperion Therapeutics Inc (ESPR) include a net sale of 7,679 shares made by Eric Warren , a net sale of 4,202 shares made by Joanne M. Foody , and a net sale of 14,550 shares made by Sheldon L. Koenig .

In summary, during the past 3 months, insiders sold 17,476 shares of Esperion Therapeutics Inc (ESPR) in total and bought 0 shares, with a net sale of 17,476 shares. During the past 18 months, 26,431 shares of Esperion Therapeutics Inc (ESPR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 26,431 shares.

Esperion Therapeutics Inc (ESPR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Esperion Therapeutics Inc Insider Transactions

No Available Data

What does Inovio Pharmaceuticals Inc do?

Who are the key executives at Inovio Pharmaceuticals Inc?

Jay Shepard is the director of Inovio Pharmaceuticals Inc. Other key executives at Inovio Pharmaceuticals Inc include Chief Medical Officer Michael John Sumner , Chief Scientific Officer Laurent Humeau , and CFO Peter Kies .

Inovio Pharmaceuticals Inc (INO) Insider Trades Summary

Over the past 18 months, Jay Shepard made no insider transaction in Inovio Pharmaceuticals Inc (INO). Other recent insider transactions involving Inovio Pharmaceuticals Inc (INO) include a net sale of 5,700 shares made by Lota S. Zoth ,

In summary, during the past 3 months, insiders sold 0 shares of Inovio Pharmaceuticals Inc (INO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 475 shares of Inovio Pharmaceuticals Inc (INO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 475 shares.

Inovio Pharmaceuticals Inc (INO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Inovio Pharmaceuticals Inc Insider Transactions

No Available Data

What does Aravive Inc do?

Who are the key executives at Aravive Inc?

Jay Shepard is the director & President and CEO of Aravive Inc. Other key executives at Aravive Inc include Chief Commercial Officer Maria Carolina Petrini , Chief Medical Officer Robert B. Geller , and Chief Financial Officer Rudy Howard .

Aravive Inc (ARAV) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Aravive Inc (ARAV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aravive Inc (ARAV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Aravive Inc (ARAV)'s detailed insider trading history can be found in Insider Trading Tracker table.

Aravive Inc Insider Transactions

No Available Data

What does Marinus Pharmaceuticals Inc do?

Who are the key executives at Marinus Pharmaceuticals Inc?

Jay Shepard is the director of Marinus Pharmaceuticals Inc. Other key executives at Marinus Pharmaceuticals Inc include Chief Commercial Officer Christina Shafer , CFO Steven Pfanstiel , and Chief Medical Officer Joseph Hulihan .

Marinus Pharmaceuticals Inc (MRNS) Insider Trades Summary

Over the past 18 months, Jay Shepard made no insider transaction in Marinus Pharmaceuticals Inc (MRNS). Other recent insider transactions involving Marinus Pharmaceuticals Inc (MRNS) include a net sale of 18,588 shares made by Scott Braunstein , a net sale of 7,730 shares made by Joseph Hulihan , and a net sale of 7,461 shares made by Steven Pfanstiel .

In summary, during the past 3 months, insiders sold 0 shares of Marinus Pharmaceuticals Inc (MRNS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 45,796 shares of Marinus Pharmaceuticals Inc (MRNS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 45,796 shares.

Marinus Pharmaceuticals Inc (MRNS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Marinus Pharmaceuticals Inc Insider Transactions

No Available Data

What does Durect Corp do?

Who are the key executives at Durect Corp?

Jay Shepard is the director of Durect Corp. Other key executives at Durect Corp include Chief Financial Officer Timothy M. Papp , Chief Medical Officer Norman Sussman , and 10 percent owner Bleichroeder Lp .

Durect Corp (DRRX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Durect Corp (DRRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Durect Corp (DRRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Durect Corp (DRRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Durect Corp Insider Transactions

No Available Data

What does Ironwood Pharmaceuticals Inc do?

Who are the key executives at Ironwood Pharmaceuticals Inc?

Jay Shepard is the director of Ironwood Pharmaceuticals Inc. Other key executives at Ironwood Pharmaceuticals Inc include Principal Accounting Officer Ronald Silver , Chief Legal Officer Minardo John , and SVP & Chief Business Officer Andrew Davis .

Ironwood Pharmaceuticals Inc (IRWD) Insider Trades Summary

Over the past 18 months, Jay Shepard made no insider transaction in Ironwood Pharmaceuticals Inc (IRWD). Other recent insider transactions involving Ironwood Pharmaceuticals Inc (IRWD) include a net sale of 307,414 shares made by Thomas A Mccourt , a net sale of 81,739 shares made by Minardo John , and a net sale of 42,163 shares made by Andrew Davis .

In summary, during the past 3 months, insiders sold 0 shares of Ironwood Pharmaceuticals Inc (IRWD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 622,069 shares of Ironwood Pharmaceuticals Inc (IRWD) were sold and 53,676 shares were bought by its insiders, resulting in a net sale of 568,393 shares.

Ironwood Pharmaceuticals Inc (IRWD)'s detailed insider trading history can be found in Insider Trading Tracker table.

Ironwood Pharmaceuticals Inc Insider Transactions

No Available Data

Jay Shepard Mailing Address

Above is the net worth, insider trading, and ownership report for Jay Shepard. You might contact Jay Shepard via mailing address: 15977 Grandview Avenue, Monte Sereno Ca 95030.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.